VYNE logo
VYNE NASDAQ US

VYNE Therapeutics Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Jan 2018
$0.60
▼ $-0.01 (-0.83%)
Vol 126K
3
Quality Score
fail
Mkt Cap
$19.3M
ROE
-80.5%
Margin
-6421.0%
D/E
0.00
Beta
2.11
52W
$0–$4

Wall Street Consensus

10 analysts · Apr 2026
2
Strong Buy
5
Buy
3
Hold
0
Sell
0
Strong Sell
70.0%
Buy Rating

Price Chart

Similar Stocks

COCP
Cocrystal Pharma Inc
$13.5M
CTXR
Citius Pharmaceuticals Inc
$16.1M
LPCN
Lipocine Inc
$44.6M
HIND
Vyome Holdings Inc
$19.4M

Earnings

Beat rate: 75.0%
Next Report May 06, 2026
EPS Estimate: $-0.18
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.18 — —
Dec 2025 $-0.18 $-0.11 +$0.07
Sep 2025 $-0.13 $-0.17 $-0.04
Jun 2025 $-0.23 $-0.13 +$0.10

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -77.1% -77.6% -77.6% -77.6% -80.5% -80.5%
P/E (TTM) — — — — — —
Net Margin -8340.6% -8097.7% -8097.7% -8097.7% -6421.0% -6421.0%
Gross Margin — 81.0% 81.0% 81.0% 81.0% 81.0%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 7.60 7.60 7.60 7.60 8.87 8.87

Key Ratios

ROA (TTM)
-65.9%
P/S (TTM)
36.85
P/B
0.9
EPS (TTM)
$-0.79
CF/Share
$-9.09
Rev Growth 3Y
-18.6%
52W High
$4.30
52W Low
$0.28
$0.28 52-Week Range $4.30

How does VYNE compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

VYNE AARD ACB ACRS ADIL

VYNE valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
36.9
▲ 644% above peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
1.0
▼ 55% below peers (2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

VYNE profitability vs Pharmaceuticals peers

ROE
-80.5%
▼ 48% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
-6421.0%
▼ 13455% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
81.0%
▲ 19% above peers (68.3%)
vs Peers
vs Industry
Weak
ROA
-65.9%
▼ 76% below peers (-37.4%)
vs Peers
vs Industry
Weak

VYNE financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
8.9
▲ 164% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.1
▲ 124% above peers (0.9)
vs Peers
vs Industry
More volatile

VYNE fundamentals radar

VYNE Peer median Industry

VYNE profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

VYNE vs peers: key metrics

Latest News

No related news yet